EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility

Ashok Agarwal iD, Taymour Mostafa iD, Manaf Al Hashimi iD, Selahittin Çayan iD, Edoardo Pescatori iD, Keerti Singh iD, Bahadır Şahin iD, Armand Zini iD, Eric Chung iD, Mohamed Arafa iD, Edmund Ko iD, Germar-M Pinggera iD und 48 weitere

The World Journal of Men's Health · 2026 · 44

DOI: 10.5534/wjmh.250290 ↗

Kurz gefasst

Leitlinie in der Zeitschrift The World Journal of Men's Health, 2026. Verfasst von Ashok Agarwal und 59 weiteren Autor:innen. Beteiligte Einrichtung: Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Global Andrology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Antioxidant (AOX) therapy has long been investigated for the management of male infertility. It has potential benefits, but persistent controversy affects its broad acceptance and clinical utility. This study aimed to develop standardized, evidence-based guidelines for AOX use by synthesizing the best available evidence and achieving global expert consensus. MATERIALS AND METHODS: A comprehensive literature review was conducted by senior experts of the Global Andrology Forum (GAF). Additionally, data on the real-life use of oxidative stress (OS) testing and AOX use obtained from the largest global survey of practicing physicians conducted by GAF, which served as a reference point for this study. In phase one, 151 international specialists (>5 years' experience) participated in a modified Delphi process to evaluate AOX therapy in male infertility. Experts reviewed draft statements and rated agreement on a 10-point Likert scale. Statements achieving >80% consensus (with score >7/10) were accepted. The original eight statements were expanded to 19 and finalized into 18. In phase two, 84 senior physicians (>10 years' experience) graded the Delphi-approved statements using the GRADE approach. RESULTS: Four out of the 18 statements failed to reach consensus and were excluded. Of the final 14 statements, seven (50%) were graded as "Strong" and seven (50%) as "Weak." Current evidence indicates that AOX therapy can reduce OS, improve sperm quality, and potentially enhance reproductive outcomes. However, benefits vary by agent, regimen, and patient population. The guidelines emphasize the need to document OS and to consider underlying factors before initiating AOX therapy, and caution against indiscriminate or prolonged use. CONCLUSIONS: Developed through a dual-validation process and endorsed by a globally diverse expert panel, these GAF guidelines represent the first standardized, evidence-based guidelines for AOX use in male infertility. By addressing heterogeneity in research and practice, they provide clinicians with practical, safe, and patient-centered recommendations for rational AOX therapy worldwide.

Schlagwörter

Stichwörter der Autor:innen

AntioxidantsDelphi techniqueGRADE approachGuidelineMale infertilitySurveys and questionnaires

Autor:innen und Institutionen

  • Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.
  • Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH, USA. agarwaa32099@outlook.com.
  • Department of Andrology, Sexology and STIs, Cairo University, Cairo, Egypt.
  • Department of Urology, Burjeel Hospital Abu Dhabi, Abu Dhabi, UAE.
  • Department of Clinical Urology, College of Medicine and Health Science, Khalifa University, Abu Dhabi, UAE.
  • Department of Urology, University of Mersin School of Medicine, Mersin, Türkiye.

ORCID-Profile: Ashok Agarwal, Taymour Mostafa, Manaf Al Hashimi, Selahittin Çayan, Edoardo Pescatori, Keerti Singh, Bahadır Şahin, Armand Zini, Eric Chung, Mohamed Arafa, Edmund Ko, Germar-M Pinggera, Ramadan Saleh, Widi Atmoko, Amarnath Rambhatla, Rossella Cannarella, Ayad Palani, Cevahir Ozer, Mohammed Abdulgabbar Noman, Fotios Dimitriadis, Tuncay Toprak, Erman Ceyhan, Juan Manuel Corral Molina, Manh Truong Nguyen, Tan V Le, Rosadi Putra, Luca Boeri, Murat Gül, Naif Alhathal, Hussein Kandil, Charalampos Thomas, Ayman Rashed, Saleh Binsaleh, Marco Falcone, Niwanda Yogiswara, Andrian Japari, Akhaine Oriazowan Julius, Gökhan Çeker, Nur Dokuzeylül Güngör, Carlo Giulioni, Islam Fathy Soliman Abdelrahman, Quang Nguyen, Gokhan Calik, Abheesh Varma Hegde, Ahmad Tarek Motawi, Satish Pundlik Dipankar, Celeste Manfredi, Akira Tsujimura, Charalampos Konstantinidis, Shedeed Ashour, Essam Aa Nada, Mohamed Al-Marhoon, Mohammed Abu El-Hamd, Moheiddin Alghobary, Nasser Mogharabian, Murtadha Almusafer, Ahmed El-Sakka, Ahmed Abd Elmoaty Khalifa, Selcuk Sarikaya, Nguyen Ho Vinh Phuoc

Förderung

  • Global Andrology Foundation

Zitieren

APA

Agarwal, A., Mostafa, T., Al Hashimi, M., Çayan, S., Pescatori, E., Singh, K., Şahin, B., Zini, A., Chung, E., Arafa, M., Ko, E., Pinggera, G. M., Saleh, R., Atmoko, W., Rambhatla, A., Cannarella, R., Palani, A., Ozer, C., Abdulgabbar Noman, M., …, & Phuoc, N. H. V. (2026). Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility. The World Journal of Men's Health, 44. https://doi.org/10.5534/wjmh.250290

Vancouver

Agarwal A, Mostafa T, Al Hashimi M, Çayan S, Pescatori E, Singh K, et al. Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility. The World Journal of Men's Health. 2026;44. doi:10.5534/wjmh.250290

BibTeX
@article{Agarwal2026,
  author = {Agarwal, Ashok and Mostafa, Taymour and Al Hashimi, Manaf and Çayan, Selahittin and Pescatori, Edoardo and Singh, Keerti and Şahin, Bahadır and Zini, Armand and Chung, Eric and Arafa, Mohamed and Ko, Edmund and Pinggera, Germar-M and Saleh, Ramadan and Atmoko, Widi and Rambhatla, Amarnath and Cannarella, Rossella and Palani, Ayad and Ozer, Cevahir and Abdulgabbar Noman, Mohammed and Dimitriadis, Fotios and Toprak, Tuncay and Ceyhan, Erman and Corral Molina, Juan Manuel and Nguyen, Manh Truong and Le, Tan V and Putra, Rosadi and Boeri, Luca and Gül, Murat and Alhathal, Naif and Kandil, Hussein and Thomas, Charalampos and Rashed, Ayman and Binsaleh, Saleh and Falcone, Marco and Yogiswara, Niwanda and Japari, Andrian and Oriazowan Julius, Akhaine and Çeker, Gökhan and Güngör, Nur Dokuzeylül and Giulioni, Carlo and Abdelrahman, Islam Fathy Soliman and Nguyen, Quang and Calik, Gokhan and Hegde, Abheesh Varma and Motawi, Ahmad Tarek and Dipankar, Satish Pundlik and Manfredi, Celeste and Tsujimura, Akira and Konstantinidis, Charalampos and Ashour, Shedeed and Nada, Essam Aa and Al-Marhoon, Mohamed and Abu El-Hamd, Mohammed and Alghobary, Moheiddin and Mogharabian, Nasser and Almusafer, Murtadha and El-Sakka, Ahmed and Khalifa, Ahmed Abd Elmoaty and Sarikaya, Selcuk and Phuoc, Nguyen Ho Vinh},
  title = {Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility},
  journal = {The World Journal of Men's Health},
  year = {2026},
  volume = {44},
  doi = {10.5534/wjmh.250290}
}
Kostenlos starten →